Ozempic tracker
For Ozempic® taken for type 2 diabetes: a weekly injection log, your own glucose and A1C readings on a chart, and records of when you started each multi-dose pen.
Not affiliated with or endorsed by Novo Nordisk or Eli Lilly. Wegovy® and Ozempic® are trademarks of Novo Nordisk A/S; Zepbound® and Mounjaro® are trademarks of Eli Lilly and Company. This page is a record-keeping tool. It doesn’t give dosing or medical advice; follow your prescriber and the product’s label.
Log an Ozempic injection
Your injection day
Glucose and A1C readings
Add the fields once, then enter readings from your meter or lab report. They chart like any other measurement.
Pens on hand
No items yet.
Everything here is the same record as the full tracker, stored in this browser only. Export or back it up from its Data tab.
What the Ozempic label says
From the OZEMPIC injection prescribing information
- Ingredient: semaglutide, a GLP-1 receptor agonist.
- Approved uses: with diet and exercise, improving glycemic control in adults with type 2 diabetes; reducing the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease; and reducing the risk of kidney disease worsening, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.
- Given once weekly, on the same day each week, at any time of day.
- Injection areas: abdomen, thigh or upper arm, changing (rotating) the site with each injection.
- Injection forms: single-patient-use pens that hold multiple weekly doses, and single-dose prefilled syringes.
- Ozempic tablets are a separate product with their own prescribing information.
Source: OZEMPIC (semaglutide) injection prescribing information, Novo Nordisk, DailyMed (version of June 1, 2026). Amounts and dose changes are deliberately left out; they’re for your prescriber and the full label.
Your readings, beside your log
The tracker doesn’t connect to a meter, so readings are what you type: a fasting glucose, an A1C from a lab report, or anything else you want to follow. Each reading is dated, so it lines up with your injection weeks on the chart and in the journal timeline. Talk to your care team about what the numbers mean; the tracker only keeps them.
Multi-dose pen records
An Ozempic pen lasts several weeks, so counting pens down per injection would be wrong. Instead, keep the number of pens on hand with automatic deduction off, and record “new pen started” each time you open one. The inventory history then doubles as a list of when each pen was started.
Ozempic, Wegovy, Mounjaro
Ozempic and Wegovy share an ingredient (semaglutide) but have different labels and approved uses; so do Mounjaro and Zepbound (tirzepatide). The Mounjaro tracker has the same glucose and A1C fields; the Wegovy tracker centres on weight.
Want weekly reminders and the same record on every device? Peptide Library’s GLP-1 tracker does that.
Label sources
Label facts on this page come only from FDA-approved prescribing information, checked November 8, 2026.
Questions
- Can I record blood glucose and A1C here?
- Yes. Add the Blood glucose and A1C fields with one tap, then enter readings from your meter or lab results. The tracker charts them; it doesn’t judge or interpret them.
- How do I keep track of a multi-dose Ozempic pen?
- Add pens on the inventory panel as a count, with automatic deduction off (each pen holds several weekly doses). When you start a new pen, use Adjust with the reason “new pen started”, so the history shows when each pen began.
- Will it tell me my Ozempic dose?
- No. The tracker never suggests amounts or dose changes. Enter the amount from your prescription.
- Is there a version for Ozempic tablets?
- Ozempic tablets have their own label and instructions. You can log them here too: change the schedule on the full tracker to match how you take them.
- Is this site affiliated with Novo Nordisk?
- No. It isn’t affiliated with or endorsed by Novo Nordisk. Ozempic® is a trademark of Novo Nordisk A/S.